Wilson Sonsini Goodrich & Rosati advised Boundless Bio on IP matters related to the transaction. Boundless Bio, a clinical-stage, next-generation precision oncology company developing innovative therapeutics...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here